ANTIOXIDANT THERAPY FOR DRY EYE DISEASE: A SYSTEMATIC REVIEW DOI Open Access

S. Harini,

Sai Mohan,

V. Chitra

et al.

International Journal of Biology Pharmacy and Allied Sciences, Journal Year: 2023, Volume and Issue: 12(10 (SPECIAL ISSUE))

Published: Oct. 12, 2023

This systematic review highlights the potential of antioxidants as therapeutic intervention in dry eye disease.Preclinical reports assessing effect plant based and synthetic against disease was collected from online electronic databases like Scopus, PubMed, Science direct, DOAJ, Jgate.The protocol registered on PROSPERO, registration no.CRD42023420934.The followed PRISMA approach for including all were appraised risk bias using SYRCLE's RoB tool.From search results 26 articles met inclusion criteria review.These analyzed rodent species strain used, which improved tear volume, restore conjunctival goblet cells, amelioration inflammatory cytokines TNF-α, IL-1β, NLRP3 reduction oxidative stress.The studies reported this insinuates target their mechanism action stress, corneal irregularity, ocular surface inflammation apoptosis secretion.These repots compositely suggest that can ameliorate negative effects improve secretion to maintain homeostasis.

Language: Английский

Exosomes derived from adipose mesenchymal stem cells promote corneal injury repair and inhibit the formation of scars by anti-apoptosis DOI

Chunli Ma,

Yixiao Li, Baoling Liu

et al.

Colloids and Surfaces B Biointerfaces, Journal Year: 2024, Volume and Issue: 247, P. 114454 - 114454

Published: Dec. 12, 2024

Language: Английский

Citations

1

Toxicity Validation of Cerium Oxide Nanoparticles and Mechanism of Action in the Treatment of Cerebral Ischemia-Reperfusion Injury DOI

Yulin Li,

Lina Guo, Yige Li

et al.

Published: Jan. 1, 2024

Language: Английский

Citations

0

Effects of La/Mn-Ceria&TiO2 Heterojunction on Titanium Implants: Improved Regenerative Repair of Diabetic Bone with Enhanced Antioxidant Characteristics DOI

Xiaoting Tang,

D. X. Lin,

Keyuan Xu

et al.

Ceramics International, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 1, 2024

Language: Английский

Citations

0

An often-overlooked health issue: The potential adverse effects of microplastics on the human ocular health DOI

Ya-Bo Bao,

Xianlei Fang,

Yiping Cheng

et al.

Critical Reviews in Environmental Science and Technology, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 21

Published: Nov. 20, 2024

Microplastics (MPs) have been detected in human tissues and body fluids, triggering obvious toxicity to health. However, the adverse effects of MPs on ocular surface were usually ignored, but receiving increasing attention now. The surface, outermost layer eye, acts as mechanical barrier exotic substances minimize interior damage. Daily exposure was considered increase risks corneal injury. In this review, we summarized sources which are most likely enter explored potential detrimental impact their adherent contaminants, well factors influencing proposed strategies reduce MPs. results showed that air, personal care products, contact lenses main Furthermore, additives adsorbents contribute more toxicities, causing some diseases like dry pterygium, conjunctivitis, keratitis. polymer type, size, degree aging, activities nature, affect Reducing plastic consumption, eliminating environmental MPs, strengthening protection important ways toxicity. Collectively, review provides new insights into health risk prevention control.

Language: Английский

Citations

0

ANTIOXIDANT THERAPY FOR DRY EYE DISEASE: A SYSTEMATIC REVIEW DOI Open Access

S. Harini,

Sai Mohan,

V. Chitra

et al.

International Journal of Biology Pharmacy and Allied Sciences, Journal Year: 2023, Volume and Issue: 12(10 (SPECIAL ISSUE))

Published: Oct. 12, 2023

This systematic review highlights the potential of antioxidants as therapeutic intervention in dry eye disease.Preclinical reports assessing effect plant based and synthetic against disease was collected from online electronic databases like Scopus, PubMed, Science direct, DOAJ, Jgate.The protocol registered on PROSPERO, registration no.CRD42023420934.The followed PRISMA approach for including all were appraised risk bias using SYRCLE's RoB tool.From search results 26 articles met inclusion criteria review.These analyzed rodent species strain used, which improved tear volume, restore conjunctival goblet cells, amelioration inflammatory cytokines TNF-α, IL-1β, NLRP3 reduction oxidative stress.The studies reported this insinuates target their mechanism action stress, corneal irregularity, ocular surface inflammation apoptosis secretion.These repots compositely suggest that can ameliorate negative effects improve secretion to maintain homeostasis.

Language: Английский

Citations

0